BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 30616453)

  • 1. Assessment of Cardiac Masses by Cardiac Magnetic Resonance Imaging: Histological Correlation and Clinical Outcomes.
    Mousavi N; Cheezum MK; Aghayev A; Padera R; Vita T; Steigner M; Hulten E; Bittencourt MS; Dorbala S; Di Carli MF; Kwong RY; Dunne R; Blankstein R
    J Am Heart Assoc; 2019 Jan; 8(1):e007829. PubMed ID: 30616453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can cardiovascular MRI be used to more definitively characterize cardiac masses initially identified using echocardiography?
    Rathi VK; Czajka AT; Thompson DV; Doyle M; Tewatia T; Yamrozik J; Williams RB; Biederman RWW
    Echocardiography; 2018 May; 35(5):735-742. PubMed ID: 29790225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular magnetic resonance imaging for diagnosis and clinical management of suspected cardiac masses and tumours.
    Fussen S; De Boeck BW; Zellweger MJ; Bremerich J; Goetschalckx K; Zuber M; Buser PT
    Eur Heart J; 2011 Jun; 32(12):1551-60. PubMed ID: 21498848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of CMR for the differential diagnosis of cardiac masses.
    Pazos-López P; Pozo E; Siqueira ME; García-Lunar I; Cham M; Jacobi A; Macaluso F; Fuster V; Narula J; Sanz J
    JACC Cardiovasc Imaging; 2014 Sep; 7(9):896-905. PubMed ID: 25129516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Performance of Cardiac Magnetic Resonance Imaging and Echocardiography in Evaluation of Cardiac and Paracardiac Masses.
    Patel R; Lim RP; Saric M; Nayar A; Babb J; Ettel M; Axel L; Srichai MB
    Am J Cardiol; 2016 Jan; 117(1):135-40. PubMed ID: 26552505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac Magnetic Resonance to Predict Cardiac Mass Malignancy: The CMR Mass Score.
    Paolisso P; Bergamaschi L; Angeli F; Belmonte M; Foà A; Canton L; Fedele D; Armillotta M; Sansonetti A; Bodega F; Amicone S; Suma N; Gallinoro E; Attinà D; Niro F; Rucci P; Gherbesi E; Carugo S; Musthaq S; Baggiano A; Pavon AG; Guglielmo M; Conte E; Andreini D; Pontone G; Lovato L; Pizzi C
    Circ Cardiovasc Imaging; 2024 Mar; 17(3):e016115. PubMed ID: 38502734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cardiac masses by CMR-strengths and pitfalls: a tertiary center experience.
    Tumma R; Dong W; Wang J; Litt H; Han Y
    Int J Cardiovasc Imaging; 2016 Jun; 32(6):913-20. PubMed ID: 26838354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The disastrous "sun ray" sign in cardiac magnetic resonance: an indicator of angiosarcoma.
    Akkaya Z; Gursoy A; Erden A
    Cardiol Young; 2014 Oct; 24(5):929-31. PubMed ID: 24702744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The usefulness of delayed contrast-enhanced cardiovascular magnetic resonance imaging in differentiating cardiac tumors from thrombi in stroke patients.
    Hong YJ; Hur J; Kim YJ; Lee HJ; Nam JE; Kim HY; Choe KO; Choi BW
    Int J Cardiovasc Imaging; 2011 Dec; 27 Suppl 1():89-95. PubMed ID: 22002687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac MRI: A Useful Tool for Differentiating Cardiac Thrombi from Tumors.
    Slonimsky E; Konen O; Di Segni E; Konen E; Goitein O
    Isr Med Assoc J; 2018 Aug; 20(8):472-475. PubMed ID: 30084570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late Gadolinium Enhancement Cardiac Magnetic Resonance Tissue Characterization for Cancer-Associated Cardiac Masses: Metabolic and Prognostic Manifestations in Relation to Whole-Body Positron Emission Tomography.
    Chan AT; Fox J; Perez Johnston R; Kim J; Brouwer LR; Grizzard J; Kim RJ; Matasar M; Shia J; Moskowitz CS; Steingart R; Weinsaft JW
    J Am Heart Assoc; 2019 May; 8(10):e011709. PubMed ID: 31072171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of Cardiac Magnetic Resonance Imaging in Diagnosing Pediatric Cardiac Masses: A Multicenter Study.
    Beroukhim RS; Ghelani S; Ashwath R; Balasubramanian S; Biko DM; Buddhe S; Campbell MJ; Cross R; Festa P; Griffin L; Grotenhuis H; Hasbani K; Hashemi S; Hegde S; Hussain T; Jain S; Kiaffas M; Kutty S; Lam CZ; Liberato G; Merlocco A; Misra N; Mowers KL; Muniz JC; Nutting A; Parra DA; Patel JK; Perez-Atayde AR; Prasad D; Rosental CF; Shah A; Samyn MM; Sleeper LA; Slesnick T; Valsangiacomo E; Geva T
    JACC Cardiovasc Imaging; 2022 Aug; 15(8):1391-1405. PubMed ID: 34419404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular magnetic resonance imaging in suspected cardiac tumour: a multicentre outcomes study.
    Shenoy C; Grizzard JD; Shah DJ; Kassi M; Reardon MJ; Zagurovskaya M; Kim HW; Parker MA; Kim RJ
    Eur Heart J; 2021 Dec; 43(1):71-80. PubMed ID: 34545397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Multimodal Cardiac Imaging in Diagnosing a Primary Intimal Sarcoma of the Left Atrial Appendage.
    Raphael KL; Martinez AP; Clements SD; Isiadinso I
    Tex Heart Inst J; 2019 Feb; 46(1):28-31. PubMed ID: 30833834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution and performance of multimodal imaging in the diagnosis and management of cardiac masses.
    Lemasle M; Lavie Badie Y; Cariou E; Fournier P; Porterie J; Rousseau H; Petermann A; Hitzel A; Carrié D; Galinier M; Marcheix B; Lairez O
    Int J Cardiovasc Imaging; 2020 May; 36(5):971-981. PubMed ID: 32040684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular magnetic resonance of primary tumors of the heart: A review.
    Fieno DS; Saouaf R; Thomson LE; Abidov A; Friedman JD; Berman DS
    J Cardiovasc Magn Reson; 2006; 8(6):839-53. PubMed ID: 17060107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac magnetic resonance evaluation of left ventricular remodelling distribution in cardiac amyloidosis.
    Pozo E; Kanwar A; Deochand R; Castellano JM; Naib T; Pazos-López P; Osman K; Cham M; Narula J; Fuster V; Sanz J
    Heart; 2014 Nov; 100(21):1688-95. PubMed ID: 25012950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer. Impact of magnetic resonance imaging.
    Burt M; Heelan RT; Coit D; McCormack PM; Bains MS; Martini N; Rusch V; Ginsberg RJ
    J Thorac Cardiovasc Surg; 1994 Feb; 107(2):584-8; discussion 588-9. PubMed ID: 8302078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First experiences with contrast-enhanced first-pass MR perfusion imaging in patients with primary, benign cardiac masses and tumour-like lesions.
    Mohrs OK; Voigtlaender T; Petersen SE; Zander M; Schulze T; Pottmeyer A; Kauczor HU
    Eur Radiol; 2008 Aug; 18(8):1617-24. PubMed ID: 18343927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left Ventricular Mass Quantification by Two-Dimensional Echocardiography in a Pediatric Population: Correlation with Cardiac Magnetic Resonance Imaging.
    Chu BJ; Lee T; Gilbreth JG; Nielsen JC; Ludomirsky A; Tretter JT; Bhatla P
    Pediatr Cardiol; 2019 Feb; 40(2):412-420. PubMed ID: 30310940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.